Justices Pass On Reviewing MS Drug Arbitration Feud

By Caroline Simson · November 9, 2026, 9:58 AM EST

The U.S. Supreme Court on Monday passed on reviewing a Second Circuit decision refusing to add some $66 million to a $16.6 million arbitral award issued to Acorda Therapeutics in a multiple...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Acorda Therapeutics, Inc., Petitioner v. Alkermes PLC

Case Number

26-498

Court

Supreme Court

Nature of Suit

Date Filed

October 15, 2026